Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
Here's Why You Should Retain Abbott (ABT) Stock for Now
03:18pm, Tuesday, 20'th Dec 2022 Zacks Investment Research
Investors continue to be optimistic about Abbott (ABT) owing to the strength in its Diabetes business and product launches.
QuidelOrtho's (QDEL) Myocardial Infarction Test Cleared in Canada
02:37pm, Tuesday, 20'th Dec 2022 Zacks Investment Research
QuidelOrtho's (QDEL) TriageTrue hsTnl Test is to be used to diagnose myocardial infarction following Health Canada's approval.
QuidelOrtho's (QDEL) Latest JV to Boost Footprint in China
06:52pm, Monday, 19'th Dec 2022 Zacks Investment Research
QuidelOrtho's (QDEL) new JV will likely translate into a faster time-to-market and a more compelling menu for VITROS assays in support of its growth strategy in China and beyond.
This Stock Is Now The Second-Largest Weight in ARKK
03:28pm, Monday, 19'th Dec 2022
There's a new top-three player in ARK's flagship ETF, the ARK Innovation Fund (ARKK). Despite CEO Cathie Wood's spree of contrarian plays for stocks like Tesla (TSLA) and Coinbase (COIN), it's the Exa
Exact Sciences (EXAS) Crossed Above the 20-Day Moving Average: What That Means for Investors
02:35pm, Monday, 19'th Dec 2022 Zacks Investment Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Exact Sciences (EXAS) Crossed Above the 20-Day Moving Average: What That Means for Investors
11:17am, Monday, 19'th Dec 2022
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Guardant Health stock plunges, Exact Sciences rises on contrasting colorectal cancer detection tests
10:58am, Friday, 16'th Dec 2022
Guardant Health Inc (NASDAQ:GH) stock plunged on Friday after the firm released results from a study of its colon cancer blood test that showed disappointing accuracy rates. Although the test accurate
Why Is Exact Sciences (EXAS) Stock Up 23% Today?
10:10am, Friday, 16'th Dec 2022
Exact Sciences (NASDAQ: EXAS ) stock is on the rise Friday following news that Guardant Health's (NASDAQ: GH ) recent clinical trial didn't go as well as expected. The big news here is GH's colon canc
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard
05:42pm, Thursday, 15'th Dec 2022
Guardant unveiled results for its colon cancer-detecting blood test Thursday that lagged rival Exact. GH stock crashed as EXAS stock jumped.
Guardant Health stock plunges, Exact Sciences stock soars after colorectal-cancer test study results
05:28pm, Thursday, 15'th Dec 2022
Shares of Guardant Health Inc. tanked 40% and shares of Exact Sciences Corp. rallied more than 25% in the extended session Thursday after Guardant announced results from a study using its blood test t
After-Hours Action: What's Going On With Guardant Health, Exact Sciences Shares? - Exact Sciences (NASDAQ:EXAS)
05:23pm, Thursday, 15'th Dec 2022
Guardant Health Inc GH and Exact Sciences Corp EXAS shares are moving in different directions in Thursday's after-hours session. Here's a look at what's going on.
Exact Sciences (EXAS) Just Reclaimed the 20-Day Moving Average
12:03pm, Thursday, 01'st Dec 2022
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
3 Healthcare Stocks That Could Set You Up For Life
08:37am, Thursday, 24'th Nov 2022
All offer products that are invaluable to their respective audiences.
5 Top Stocks Cathie Wood Is Buying This Week
05:16pm, Friday, 04'th Nov 2022
Shares of Cathie Wood's flagship exchange-traded fund (ETF), the ARK Innovation ETF (NYSEARCA: ARKK ), are now down more than 60% year-to-date (YTD). Earlier this week, the Federal Reserve dealt anoth
Exact Sciences (EXAS) Q3 Earnings Top Estimates, Margin Falls
12:03pm, Friday, 04'th Nov 2022
Exact Sciences (EXAS) registers robust revenues from the Screening and Precision Oncology segments in Q3.
